Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine
NCT03497572 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 145
Last updated 2018-05-08
Summary
The study aims to assess antibody persistence induced by Spirolept® vaccination in subjects who received at least 4 doses (2 doses two weeks apart and 2 booster doses) and no more than a total of 8 doses (2 doses two weeks apart and 6 booster doses).
Conditions
- Leptospirosis
Sponsors & Collaborators
-
Imaxio
lead INDUSTRY
Principal Investigators
-
Maryse Beder, MD · SIAAP
-
Simonetta Viviani, MD · Imaxio
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-08-25
- Primary Completion
- 2018-04-12
- Completion
- 2018-04-12
Countries
- France
Study Locations
More Related Trials
-
Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years
NCT00161785 ·Status: COMPLETED ·Phase: PHASE4
-
Perceptions,Social Representations and Experience of Lyme Borreliosis and Ticks in Adolescents Likely to be Infected and Their Parents
NCT05678478 ·Status: COMPLETED
-
Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.
NCT03769194 ·Status: COMPLETED ·Phase: PHASE2
-
Borrelia Species in Cutaneous Lyme Borreliosis
NCT00576082 ·Status: UNKNOWN
-
Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease
NCT06611111 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Phase 1/2 Lyme Vaccine Study
NCT01504347 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease
NCT00001101 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children
NCT05634811 ·Status: COMPLETED ·Phase: PHASE3
-
Disulfiram: A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease
NCT03891667 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Clinical, Microbiological and Epidemiological Characteristics of Recurrent Imported Borreliosis Confirmed by the CNR Borrelia
NCT07335965 ·Status: RECRUITING
-
Understanding Tick-borne Diseases
NCT03501407 ·Status: UNKNOWN
-
Evaluation, Treatment, and Follow-up of Patients With Lyme Disease
NCT00028080 ·Status: RECRUITING
-
A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease
NCT02741609 ·Status: TERMINATED ·Phase: NA
-
QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001
NCT05092438 ·Status: COMPLETED
-
64Cu-DOTATATE-PET for Lyme Neuroborreliosis
NCT06392815 ·Status: RECRUITING ·Phase: NA
-
A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults
NCT07226882 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Performance Evaluation of the DualDur In Vitro Diagnostic System in the Diagnosis of Lyme Borreliosis
NCT03873974 ·Status: COMPLETED
-
Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus
NCT06820060 ·Status: ACTIVE_NOT_RECRUITING
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease
NCT00000938 ·Status: COMPLETED ·Phase: PHASE3
-
Direct Diagnosis of Disseminated Lyme Borreliosis.
NCT04719962 ·Status: UNKNOWN ·Phase: NA
-
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
NCT00001539 ·Status: RECRUITING
-
Impact on the Quality of Life and Persistent Symptoms of Patients Away From Diagnosed and Treated Neuroborreliosis
NCT05742139 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
NCT05975099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Biomarker Study of Previously Treated Lyme Disease Volunteers in Comparison to Healthy Volunteers
NCT04835792 ·Status: UNKNOWN
-
Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis
NCT03010228 ·Status: COMPLETED ·Phase: PHASE1